Add BrightSurf on Google Email

Salk Institute


New molecule reverses Alzheimer's-like memory decline

A new study published in Redox Biology shows that the drug CMS121 successfully reversed memory loss in a mouse model of inherited Alzheimer's disease. The drug works by normalizing lipid peroxidation and lowering levels of fatty acid synthetase, suggesting FASN as a potential target for treating Alzheimer's disease.

SourceSalk Institute·JournalRedox Biology·DateAug 4, 2020

Giant leap in diagnosing liver disease

A novel microbiome-based diagnostic tool has been developed to quickly and inexpensively identify liver fibrosis and cirrhosis in patients. The non-invasive method analyzes patient stool samples and achieves an accuracy of over 90% in diagnosing cirrhosis, with potential implications for improving treatment outcomes.

SourceSalk Institute·JournalCell Metabolism·DateJul 1, 2020

How cells solve their identity crisis

A team of scientists has provided clarity into how new cells remember their identity after cell division. They found that many genes are activated immediately after cell division, acting in a cascade to send critical signals and allow the cell to 'wake up' from its cellular amnesia.

SourceSalk Institute·JournalGenes & Development·DateJun 4, 2020

Boosting levels of good fats with an experimental drug that acts on two newly characterized genes

Researchers at Salk Institute discover two genes that regulate levels of healthy fats called FAHFAs, which decrease inflammation and increase insulin sensitivity. An experimental drug successfully increases FAHFA levels by blocking the activity of these genes, offering new insights into therapies for metabolic and inflammatory diseases.

SourceSalk Institute·JournalJournal of Biological Chemistry·DateMay 1, 2020

How plants sound the alarm about danger

A team of scientists has discovered a complex communication network in plants that responds to the hormone jasmonic acid, allowing them to defend against insects and fungi. The study reveals two key genes, MYC2 and MYC3, which play a crucial role in regulating plant defense responses.

SourceSalk Institute·JournalNature Plants·DateMar 13, 2020

Eat less, live longer

A new study by Salk scientists shows that caloric restriction can protect against aging in cellular pathways, reducing inflammation and increasing life span. The study found that 57% of age-related changes in cell composition were not present in rats on a restricted diet.

SourceSalk Institute·JournalCell·DateFeb 27, 2020

The first roadmap for ovarian aging

Researchers analyzed ovarian cells from young and old non-human primates to understand ovarian aging. They identified genes that could be used as biomarkers and point to therapeutic targets for diagnosing and treating female infertility and age-associated ovarian diseases.

SourceSalk Institute·JournalCell·DateJan 30, 2020

Drug combo reverses arthritis in rats

A combination of two experimental drugs has reversed osteoarthritis in rats, with improved cartilage thickness and reduced cell death. The treatment may potentially translate to human use, offering a promising therapy for millions of adults affected by the disease.

SourceSalk Institute·JournalProtein & Cell·DateJan 21, 2020

Finding the smallest genes could yield outsized benefits

A study from the Salk Institute identified over 2,000 previously unknown small open reading frames (smORFs) in human cell lines, expanding the number of human genes by 10%. These tiny genetic sequences may hold key to understanding human biology and developing new treatments for diseases like cancer and diabetes.

SourceSalk Institute·JournalNature Chemical Biology·DateDec 9, 2019

Three types of cells help the brain tell day from night

Researchers at Salk Institute discover intrinsically photosensitive retinal ganglion cells (ipRGCs) in humans, which respond to blue light and help establish healthy day-night cycles. The study's findings may lead to 'smart' lights that prevent depression, foster sleep, and maintain circadian rhythms.

SourceSalk Institute·JournalScience·DateDec 5, 2019

Brain biomarker predicts compulsive drinking

Researchers at Salk Institute discover a brain circuit controlling alcohol drinking behavior in mice, which can predict compulsive drinking. The study found that neural communication patterns between two brain regions are related to the development of compulsive drinking.

SourceSalk Institute·JournalScience·DateNov 21, 2019

Unlocking the black box of embryonic development

A team of international scientists has developed a new method for culturing primate embryos in the lab, allowing them to study early developmental processes for the first time. The breakthrough provides valuable insight into embryonic development and potentially informs approaches to advance regenerative medicine in humans.

SourceSalk Institute·JournalScience·DateOct 31, 2019

Mapping normal breast development to better understand cancer

Researchers used state-of-the-art technology to profile each cell during normal breast development, creating a molecular map to understand how breast tissues are formed and maintained. The team found that cells were already poised to become either basal or luminal cells before birth, with abnormal alterations leading to tumor development.

SourceSalk Institute·JournalCell Reports·DateOct 8, 2019

Finding a cause of neurodevelopmental disorders

Researchers identified the molecular mechanism linking a protein mutation with abnormal nervous system development in neurodevelopmental disorders. A complex of proteins called the SWI/SNF complex was found to be affected, leading to changes in gene expression and brain development.

SourceSalk Institute·JournalMolecular Cell·DateJul 30, 2019

Two therapeutic targets identified for deadly lung cancer

Researchers have discovered that two enzymes, SIK1 and SIK3, play a critical role in driving tumor growth in non-small-cell lung cancer by promoting inflammation. The findings highlight a potential new target for therapies and could lead to improved treatment options for patients with this deadly form of lung cancer.

SourceSalk Institute·JournalCancer Discovery·DateJul 26, 2019

Unlocking therapies for hard-to-treat lung cancers

A new study published in Science Advances reveals that a cellular switch called CREB plays a key role in directing tumor growth in non-small-cell lung cancer. Researchers found that blocking this switch could have therapeutic benefits for patients with this deadly type of cancer.

SourceSalk Institute·JournalScience Advances·DateJul 24, 2019

Plants are also stressed out

Researchers discover GUN1 plays a crucial role in regulating chloroplast-to-nucleus communication, enabling plants to respond to stress. This finding may help breed plants that can better withstand environmental stressors and maintain food production.

SourceSalk Institute·JournalProceedings of the National Academy of Sciences·DateApr 19, 2019

New role for a driver of metastatic cancers

Salk scientists discovered a new mechanism of action for the CDK12 protein, revealing its role in regulating gene expression and cell division. This finding suggests that targeting CDK12 could be an effective way to kill cancer cells and improve treatment outcomes.

SourceSalk Institute·JournalGenes & Development·DateApr 2, 2019